Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Favourable Outcomes in Newly Diagnosed Paediatric AML with Gemtuzumab Ozogamicin and Risk-Stratified Therapy: Results from the International Phase III Myechild 01 Trial

Blood (2024) 144 (Supplement 1): 968.

https://doi.org/10.1182/blood-2024-198419

Published: 2024

Journal Articles

Nilotinib with or without cytarabine for Philadelphia-positive acute lymphoblastic leukemia

Blood (2024) 143 (23): 2363–2372.

https://doi.org/10.1182/blood.2023023502

Published: 2024

Includes: Supplemental data

Journal Articles

Outcomes for Children with High Risk Acute Myeloid Leukemia on the Myechild 01 International Phase III Clinical Trial

Blood (2023) 142 (Supplement 1): 730.

https://doi.org/10.1182/blood-2023-181593

Published: 2023

Journal Articles

PAX5 P80R mutation identifies a novel subtype of B-cell precursor acute lymphoblastic leukemia with favorable outcome

Blood (2019) 133 (3): 280–284.

https://doi.org/10.1182/blood-2018-10-882142

Published: 2019

Includes: Supplemental data

Journal Articles

Impact of cytogenetic abnormalities in adults with Ph-negative B-cell precursor acute lymphoblastic leukemia

Blood (2017) 130 (16): 1832–1844.

https://doi.org/10.1182/blood-2017-05-783852

Published: 2017

Includes: Supplemental data

Journal Articles

Dasatinib and low-intensity chemotherapy in elderly patients with Philadelphia chromosome–positive ALL

Blood (2016) 128 (6): 774–782.

https://doi.org/10.1182/blood-2016-02-700153

Published: 2016

Includes: Supplemental data

Journal Articles

Randomized study of reduced-intensity chemotherapy combined with imatinib in adults with Ph-positive acute lymphoblastic leukemia

Blood (2015) 125 (24): 3711–3719.

https://doi.org/10.1182/blood-2015-02-627935

Published: 2015

Includes: Supplemental data

Journal Articles

Value of Cytogenetic Abnormalities in Adult Patients with Philadelphia Chromosome (Ph)-Negative Acute Lymphoblastic Leukemia (ALL) Treated in the Pediatric-Inspired Trials from the Group for Research on Adult ALL (GRAALL)

Blood (2014) 124 (21): 492.

https://doi.org/10.1182/blood.V124.21.492.492

Published: 2014

Journal Articles

Wide diversity of PAX5 alterations in B-ALL: a Groupe Francophone de Cytogénétique Hématologique study

Blood (2010) 115 (15): 3089–3097.

https://doi.org/10.1182/blood-2009-07-234229

Published: 2010

Includes: Supplemental data

Journal Articles

Prognosis of Patients with AML Carrying 11Q23/MLL Reciprocal Translocations : A Retrospective Study of 191 Cases from the French AML-Intergroup

Blood (2008) 112 (11): 2547.

https://doi.org/10.1182/blood.V112.11.2547.2547

Published: 2008

Journal Articles

Myeloid Cell Differentiation Arrest by Mir-125b-1 in Myelodysplasic Syndrome and Acute Myeloid Leukemia with the T(2;11)(p21;q23) Translocation

Marina Bousquet, Cathy Quelen, Roberto Rosati, Véronique Mansat-De Mas, Christian Bastard, Eric Lippert, Pascaline Talmant, Marina Lafage-Pochitaloff, Dominique Leroux, Carine Gervais, Franck Viguie, Jean-Luc Lai, Christine Terre, Georges Delsol, Nicole Dastugue, Cristina Mecucci, Pierre Brousset

Blood (2008) 112 (11): 4148.

https://doi.org/10.1182/blood.V112.11.4148.4148

Published: 2008

Journal Articles

PAX5 Mutations Occur Frequently in Adult B-Cell Acute Lymphoblastic Leukemia (B-ALL) and Is Significantly Associated with BCR-ABL1 Fusion Gene.

Blood (2007) 110 (11): 2806.

https://doi.org/10.1182/blood.V110.11.2806.2806

Published: 2007

Journal Articles

Prognostic Significance of CD20 Expression in Adult B-Cell Precursor Acute Lymphoblastic Leukemia.

Blood (2007) 110 (11): 2829.

https://doi.org/10.1182/blood.V110.11.2829.2829

Published: 2007

Journal Articles

HOX11L2 / TLX3 is transcriptionally activated through T-cell regulatory elements downstream of BCL11B as a result of the t(5;14)(q35;q32)

Xin-Ying Su, Véronique Della-Valle, Isabelle Andre-Schmutz, Claudie Lemercier, Isabelle Radford-Weiss, Paola Ballerini, Michel Lessard, Marina Lafage-Pochitaloff, Francine Mugneret, Roland Berger, Serge P. Romana, Olivier A. Bernard, Virginie Penard-Lacronique

Blood (2006) 108 (13): 4198–4201.

https://doi.org/10.1182/blood-2006-07-032953

Published: 2006

Includes: Supplemental data

Journal Articles

Allogeneic Stem Cell Transplantation (allo-SCT) in Patients with Secondary Acute Myelogenous Leukemia (AML) or High Risk Myelodysplastic Syndromes (MDS).

Jean El-Cheikh, Catherine Faucher, Mohamad Mohty, Anne-Marie Stoppa, Marina Lafage-Pochitaloff, Diane Coso, Marie-Joelle Moziconacci, Reda Bouabdallah, Jean-Albert Gastaut, Didier Blaise, Norbert Vey

Blood (2005) 106 (11): 5416.

https://doi.org/10.1182/blood.V106.11.5416.5416

Published: 2005

Journal Articles

Age-related phenotypic and oncogenic differences in T-cell acute lymphoblastic leukemias may reflect thymic atrophy

Vahid Asnafi, Kheira Beldjord, Marta Libura, Patrick Villarese, Corrine Millien, Paola Ballerini, Emilienne Kuhlein, Marina Lafage-Pochitaloff, Eric Delabesse, Olivier Bernard, Elizabeth Macintyre

Blood (2004) 104 (13): 4173–4180.

https://doi.org/10.1182/blood-2003-11-3944

Published: 2004

Journal Articles

CALM-AF10 is a common fusion transcript in T-ALL and is specific to the TCRγδ lineage

Vahid Asnafi, Isabelle Radford-Weiss, Nicole Dastugue, Chantal Bayle, Daniel Leboeuf, Christiane Charrin, Richard Garand, Marina Lafage-Pochitaloff, Eric Delabesse, Agnès Buzyn, Xavier Troussard, Elizabeth Macintyre

Blood (2003) 102 (3): 1000–1006.

https://doi.org/10.1182/blood-2002-09-2913

Published: 2003

Journal Articles

Cytogenetic profile of childhood and adult megakaryoblastic leukemia (M7): a study of the Groupe Français de Cytogénétique Hématologique (GFCH)

Nicole Dastugue, Marina Lafage-Pochitaloff, Marie-Pierre Pagès, Isabelle Radford, Christian Bastard, Pascaline Talmant, Marie Joelle Mozziconacci, Claude Léonard, Christelle Bilhou-Nabéra, Christine Cabrol, Anne-Marie Capodano, Pascale Cornillet-Lefebvre, Michel Lessard, Francine Mugneret, Christine Pérot, Sylvie Taviaux, Odile Fenneteaux, Eliane Duchayne, Roland Berger

Blood (2002) 100 (2): 618–626.

https://doi.org/10.1182/blood-2001-12-0241

Published: 2002

Journal Articles

CD4 + , CD56 + DC2 acute leukemia is characterized by recurrent clonal chromosomal changes affecting 6 major targets: a study of 21 cases by the Groupe Français de Cytogénétique Hématologique

Dominique Leroux, Francine Mugneret, Mary Callanan, Isabelle Radford-Weiss, Nicole Dastugue, Jean Feuillard, Franseza Le Mée, Ghislaine Plessis, Pascaline Talmant, Nathalie Gachard, Françoise Uettwiller, Marie-Pierre Pages, Marie-Joëlle Mozziconacci, Virginie Eclache, Catherine Sibille, Hervé Avet-Loiseau, Marina Lafage-Pochitaloff

Blood (2002) 99 (11): 4154–4159.

https://doi.org/10.1182/blood.V99.11.4154

Published: 2002

Journal Articles

Defective expression and function of natural killer cell–triggering receptors in patients with acute myeloid leukemia

Régis T. Costello, Simona Sivori, Emanuela Marcenaro, Marina Lafage-Pochitaloff, Marie-Joelle Mozziconacci, Denis Reviron, Jean-Albert Gastaut, Daniela Pende, Daniel Olive, Alessandro Moretta

Blood (2002) 99 (10): 3661–3667.

https://doi.org/10.1182/blood.V99.10.3661

Published: 2002

NARROW

Favourable Outcomes in Newly Diagnosed Paediatric AML with Gemtuzumab Ozogamicin and Risk-Stratified Therapy: Results from the International Phase III Myechild 01 Trial

Nilotinib with or without cytarabine for Philadelphia-positive acute lymphoblastic leukemia

Outcomes for Children with High Risk Acute Myeloid Leukemia on the Myechild 01 International Phase III Clinical Trial

PAX5 P80R mutation identifies a novel subtype of B-cell precursor acute lymphoblastic leukemia with favorable outcome

Impact of cytogenetic abnormalities in adults with Ph-negative B-cell precursor acute lymphoblastic leukemia

Dasatinib and low-intensity chemotherapy in elderly patients with Philadelphia chromosome–positive ALL

Randomized study of reduced-intensity chemotherapy combined with imatinib in adults with Ph-positive acute lymphoblastic leukemia

Value of Cytogenetic Abnormalities in Adult Patients with Philadelphia Chromosome (Ph)-Negative Acute Lymphoblastic Leukemia (ALL) Treated in the Pediatric-Inspired Trials from the Group for Research on Adult ALL (GRAALL)

Wide diversity of PAX5 alterations in B-ALL: a Groupe Francophone de Cytogénétique Hématologique study

Prognosis of Patients with AML Carrying 11Q23/MLL Reciprocal Translocations : A Retrospective Study of 191 Cases from the French AML-Intergroup

Myeloid Cell Differentiation Arrest by Mir-125b-1 in Myelodysplasic Syndrome and Acute Myeloid Leukemia with the T(2;11)(p21;q23) Translocation

PAX5 Mutations Occur Frequently in Adult B-Cell Acute Lymphoblastic Leukemia (B-ALL) and Is Significantly Associated with BCR-ABL1 Fusion Gene.

Prognostic Significance of CD20 Expression in Adult B-Cell Precursor Acute Lymphoblastic Leukemia.

HOX11L2 / TLX3 is transcriptionally activated through T-cell regulatory elements downstream of BCL11B as a result of the t(5;14)(q35;q32)

Allogeneic Stem Cell Transplantation (allo-SCT) in Patients with Secondary Acute Myelogenous Leukemia (AML) or High Risk Myelodysplastic Syndromes (MDS).

Age-related phenotypic and oncogenic differences in T-cell acute lymphoblastic leukemias may reflect thymic atrophy

CALM-AF10 is a common fusion transcript in T-ALL and is specific to the TCRγδ lineage

Cytogenetic profile of childhood and adult megakaryoblastic leukemia (M7): a study of the Groupe Français de Cytogénétique Hématologique (GFCH)

CD4 + , CD56 + DC2 acute leukemia is characterized by recurrent clonal chromosomal changes affecting 6 major targets: a study of 21 cases by the Groupe Français de Cytogénétique Hématologique

Defective expression and function of natural killer cell–triggering receptors in patients with acute myeloid leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only